CELLTRION PHARM LNC

Company Introduction:

CELLTRION PHARM LNC (more commonly known as Celltrion Pharm Inc.) is a pharmaceutical company based in South Korea. It is a key affiliate of the Celltrion Group, a leading biopharmaceutical company globally recognized for its innovative biosimilar and new drug development. Celltrion Pharm Inc. is primarily involved in the manufacturing, development, and sales of a wide range of pharmaceutical products, including ethical drugs, over-the-counter medications, and biosimilars. The company leverages advanced biotechnological capabilities and robust manufacturing facilities to produce high-quality pharmaceutical goods that are distributed both domestically and internationally. Its focus is on providing accessible and effective healthcare solutions to patients.

Nature of Business:

Factory. Celltrion Pharm LNC is a manufacturer of pharmaceutical products.

Here are some products manufactured or sold by CELLTRION PHARM INC (South Korea):

* **Remsima SC (Infliximab):** Subcutaneous formulation of infliximab, a biosimilar of Remicade, used for treating autoimmune diseases.

* **Herzuma (Trastuzumab):** A biosimilar of Herceptin, used in the treatment of certain breast and gastric cancers.

* **Truxima (Rituximab):** A biosimilar of Rituxan/MabThera, used in the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

* **Vegzelma (Bevacizumab):** A biosimilar of Avastin, used in the treatment of several types of cancer.

* **Various pharmaceuticals:** Including but not limited to treatments for cardiovascular diseases, diabetes, and other common ailments. (The specific range of these products can vary.)